-

Claritas Rx Named to the 2025 Inc. 5000 List, Ranking Among America’s Fastest-Growing Private Companies

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the leader in intelligent solutions that provide real-time visibility across the entire patient journey, announced today it has been named to the prestigious Inc. 5000 list, the most respected ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses. Past honorees include companies such as Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle and Patagonia.

“Our mission to redefine care coordination for rare and specialty patients is what is driving our team – the growth and success we have had is a bonus," said Michael Fitzgibbons, CEO of Claritas Rx.

Share

“We are thrilled to be included on this year’s Inc. 5000 list,” said Michael Fitzgibbons, CEO of Claritas Rx. “Our mission to redefine care coordination for rare and specialty patients is what is driving our team—the growth and success we have had is a bonus. Supporting our life science clients to have better clarity and control in ensuring patients start and stay on therapy is the foundation that we will continue to grow our business on.”

This year’s Inc. 5000 honorees have demonstrated exceptional growth while navigating economic uncertainty, inflationary pressure, and a fluctuating labor market. For the full list, visit: www.inc.com/inc5000.

“Making the Inc. 5000 is always a remarkable achievement, but earning a spot this year speaks volumes about a company’s tenacity and clarity of vision,” says Mike Hofman, editor-in-chief of Inc. “These businesses have thrived amid rising costs, shifting global dynamics, and constant change. They didn’t just weather the storm—they grew through it, and their stories are a powerful reminder that the entrepreneurial spirit is the engine of the U.S. economy.”

About Inc.

Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.

About Claritas Rx

Based in South San Francisco, CA, Claritas Rx’s intelligent suite of solutions provides real-time visibility across the entire patient journey. The Company’s products allow biopharma companies to see what others miss, identifying the exact points where access and adherence break down while coordinating communications so that care teams can proactively intervene. This powerful combination of clarity and control gives patient services teams the ability to act and ensure more patients start and stay on therapy. For more information, visit www.claritasrx.com.

Claritas Rx


Release Versions

More News From Claritas Rx

Claritas Rx Appoints Biopharma Commercial Leader Jonathan Witt to Board of Directors

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced the appointment of Jonathan Witt to its Board of Directors. Mr. Witt is an accomplished senior executive with more than 25 years of experience in U.S. and global biopharmaceutical roles. He has a proven record of evaluating market opportunities across diverse therapeutic areas, setting development, commercialization, and corporate strategy, building and scaling enterprise capabilities, and tr...

Relay Network and Claritas Rx Announce Strategic Partnership to Advance Patient Engagement for Specialty and Rare Disease Programs

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, and Relay Network, a leader in HIPAA-Compliant, mobile-first patient engagement, today announced a strategic partnership to help life sciences companies close critical gaps in patient access, support, and adherence. The collaboration combines Claritas Rx’s specialty pharmacy, hub, and program-level data with Relay Network’s interactive, feed-based communication channel to deliver personalized, 1:1 mobile exp...

Everest Group Finds Patients in Rare and Specialty Markets Are Getting More Touches and Less Help

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced the release of a new Everest Group white paper: From Fragmented to Orchestrated: Omnichannel Engagement in Patient Services. The white paper addresses a persistent challenge in life sciences: despite significant investment in omnichannel patient engagement, most patient support programs still deliver fragmented, inconsistent experiences. Patients receive repeated outreach, conflicting guidance...
Back to Newsroom